Risk assessment in pulmonary arterial hypertension (pah): insights from the griphon study

Approaches to risk assessment in pulmonary arterial hypertension (PAH) include the non-invasive French risk assessment approach (number of low-risk criteria based on the ESC/ERS guidelines) and REVEAL 2.0 risk calculator. The prognostic and predictive value of these methods for morbidity/mortality was evaluated in the predominantly prevalent population of GRIPHON, the largest randomized controlled trial in PAH.

Source: The Journal of Heart and Lung Transplantation - January 20, 2020 Category: Transplant Surgery Authors: Olivier Sitbon, Kelly M. Chin, Richard N. Channick, Raymond L. Benza, Lilla Di Scala, Sean Gaine, Hossein-Ardeschir Ghofrani, Irene M. Lang, Vallerie V. McLaughlin, Ralph Preiss, Lewis J. Rubin, G érald Simonneau, Victor F. Tapson, Nazzareno Galiè, Mari Tags: Original Clinical Science Source Type: research